Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells

    TNFR2 expression is a characteristic of highly potent immunosuppressive tumor infiltrating CD4+Foxp3+ regulatory T cells (Tregs). There is compelling evidence that TNF through TNFR2 preferentially stimulates the ...

    Tianzhen He, Yibo Chen, De Yang, Md Sahidul Islam, Chon-Kit Chou in Cellular Oncology (2023)

  2. Article

    Open Access

    Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses

    Cryptotanshinone (CT), a purified compound initially isolated from the dried roots of Salvia militorrhiza. Bunge, exhibits cytotoxic antitumor effects on many tumors. We have shown that CT possesses the dual cap...

    Zhen Han, Shuo Liu, Hongsheng Lin, Anna L. Trivett in Cancer Immunology, Immunotherapy (2019)

  3. Article

    Open Access

    Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma

    Lung cancer is currently the leading cause of cancer-related mortality with very limited effective therapy. Screening of a variety of traditional Chinese medicines (TCMs) for their capacity to inhibit the prol...

    Shuo Liu, Zhen Han, Anna L. Trivett, Hongsheng Lin in Cancer Immunology, Immunotherapy (2019)

  4. Article

    Open Access

    Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice

    Transient depletion of CD4+ T cells results in tumor suppression and survival benefit in murine models; however, the tumor progression and recurrence still occur over more long-term monitoring of mice. Thus, we e...

    Chang-Yu Chen, Satoshi Ueha, Yoshiro Ishiwata in Journal for ImmunoTherapy of Cancer (2019)

  5. Article

    Open Access

    Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors

    Harnessing immune system to treat cancer requires simultaneous generation of tumor-specific CTLs and curtailment of tumor immunosuppressive environment. Here, we developed an immunotherapeutic regimen capable ...

    Yingjie Nie, De Yang, Anna Trivett, Zhen Han, Haiyun **n, **n Chen in Scientific Reports (2017)

  6. No Access

    Article

    Paradoxical effects of targeting TNF signalling in the treatment of autoimmunity

    Adalimumab, an anti-TNF monoclonal antibody used to treat rheumatoid arthritis and other autoimmune disorders, paradoxically enhances the capacity of TNF to expand TNF receptor type II-expressing regulatory T ...

    **n Chen, Joost J. Oppenheim in Nature Reviews Rheumatology (2016)

  7. Article

    Open Access

    Correction: Corrigendum: TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis

    Scientific Reports 6: Article number: 32834; published online: 07 September 2016; updated: 13 October 2016

    **n Chen, Yingjie Nie, Haitao **ao, Zhaoxiang Bian in Scientific Reports (2016)

  8. Article

    Open Access

    TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis

    There is now compelling evidence that TNFR2 is constitutively expressed on CD4+ Foxp3+ regulatory T cells (Tregs) and TNF-TNFR2 interaction is critical for the activation, expansion and functional stability of Tr...

    **n Chen, Yingjie Nie, Haitao **ao, Zhaoxiang Bian in Scientific Reports (2016)

  9. No Access

    Article

    Suppressive activity of human regulatory T cells is maintained in the presence of TNF

    Bruno Zaragoza, **n Chen, Joost J Oppenheim, Audrey Baeyens in Nature Medicine (2016)

  10. No Access

    Article

    Characterization of MT-2 cells as a human regulatory T cell-like cell line

    Ryoko Hamano, Xueqiang Wu, Yitao Wang, Joost J Oppenheim in Cellular & Molecular Immunology (2015)

  11. No Access

    Chapter and Conference Paper

    Alarmins Initiate Host Defense

    In response to infection and/or tissue injury, cells of the host innate immune system rapidly produce a variety of structurally distinct mediators (we elect to call alarmins) that not only function as potent e...

    Joost J. Oppenheim, Poonam Tewary, Gonzalo de la Rosa, De Yang in Immune-Mediated Diseases (2007)

  12. No Access

    Chapter

    Crosstalk between chemokine, opioid, and vanilloid receptors

    Ning Zhang, Joost J. Oppenheim in Chemokine Biology — Basic Research and Cli… (2006)

  13. No Access

    Chapter

    Biology of chemokines

    Gao **, Ji Ming Wang, O. M. Zack Howard in Lymphocyte Trafficking in Health and Disea… (2006)

  14. No Access

    Article

    Temporin/VesCP (T/V)-like antibiotic peptides, derived from frogs and wasps, induce migration of human monocytes and neutrophils

    Several naturally occurring antimicrobial peptides, from mammals and insects, have previously been shown to be chemotactic for human inflammatory cells. Based on this evidence, ten synthetic analogs of natural...

    De Yang, Qian Chen, Joost J. Oppenheim, Pentti Kuusela in Letters in Peptide Science (2003)

  15. Article

    Chemokine receptors on dendritic cells promote autoimmune reactions

    This paper presents a brief review of several lines of evidence suggesting that chemokine receptors on dendritic cells play an important role in breaking tolerance to self and in inducing autoimmunity. First, ...

    Joost J Oppenheim, De Yang, Arya Biragyn, OM Zack Howard in Arthritis Research & Therapy (2002)

  16. No Access

    Article

    Cytokines: Past, Present, and Future

    This review provides an historical account of the discovery and development of cytokines. Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers ...

    Joost J. Oppenheim in International Journal of Hematology (2001)

  17. No Access

    Chapter

    Interactions of Opioid Receptors, Chemokines, and Chemokine Receptors

    Imre Szabo, Michele Wetzel, Lois McCarthy in Neuroimmune Circuits, Drugs of Abuse, and … (2001)

  18. Article

    Chemokines as Molecular Targets for Therapeutic Intervention

    Despite the youth of the chemokine field, many antagonists of chemokine function have already been identified and tested at the preclinical level. These include neutralizing antibodies, peptidyl and non-peptid...

    O. M. Zack Howard, Joost J. Oppenheim, Ji Ming Wang in Journal of Clinical Immunology (1999)

  19. No Access

    Article

    New Insights into the Biology of the Acute Phase Response

    Innate or natural immunity is a highly conserved defense mechanism against infection found in all multicellular organisms. The acute phase response is the set of immediate inflammatory responses initiated by p...

    Anthony F. Suffredini, Giamila Fantuzzi in Journal of Clinical Immunology (1999)

  20. No Access

    Chapter

    Chemokine Modulation of Tumor Cell Physiology

    Leukocyte infiltration into inflamed or injured tissues is regulated by a variety of cell-associated and soluble factors that mediate the communications between circulating leukocytes and vascular endothelial ...

    Ji Ming Wang, Weipin Shen, Oleg Chertov, Jo Van Damme in Chemokines and Cancer (1999)

previous disabled Page of 2